These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8701129)
21. [Contribution to corticosteroid allergy]. Esser B Z Hautkr; 1983 Jan; 58(1):29-32. PubMed ID: 6219504 [TBL] [Abstract][Full Text] [Related]
22. Fluocinonide: a new topical corticosteroid for psoriasis and other dermatoses. Counce JH; Brass A J La State Med Soc; 1972 Oct; 124(10):365-7. PubMed ID: 5079531 [No Abstract] [Full Text] [Related]
23. [Contact acne: example of a civilization dermatosis. 2]. Weirich EG Derm Beruf Umwelt; 1978; 26(2):45-52. PubMed ID: 157863 [No Abstract] [Full Text] [Related]
24. [Question of the Month. How do you prescribe the quantity of topical corticoids to be used?]. Crickx B Ann Dermatol Venereol; 1999; 126(6-7):547-52. PubMed ID: 10495873 [No Abstract] [Full Text] [Related]
26. [Clinical effectiveness of fluocinonide in several skin diseases]. Tomoka MT; Ochoa AG Wien Med Wochenschr; 1973 Apr; 123(15):247-8. PubMed ID: 4267190 [No Abstract] [Full Text] [Related]
27. Allergic reactions to topical (surface) anesthetics with reference to the safety of tronothane (pramoxine hydrochloride). Fisher AA Cutis; 1980 Jun; 25(6):584, 586, 589-91 passim. PubMed ID: 7379587 [No Abstract] [Full Text] [Related]
28. Itching for a solution: how topical steroids became a standard treatment for eczema. Nally E Pharm Hist (Lond); 2014 Sep; 44(3):56-64. PubMed ID: 25335225 [No Abstract] [Full Text] [Related]
29. [Classification of local corticoids sold in France]. Queille C; Saurat JH Ann Dermatol Venereol; 1980; 107(11):1091-2. PubMed ID: 7235491 [No Abstract] [Full Text] [Related]
30. Discussion of paper by Frances Pascher, M.D.: systemic reactions to tropically applied drugs. Berger H Bull N Y Acad Med; 1973 Jul; 49(7):628-33. PubMed ID: 4514300 [No Abstract] [Full Text] [Related]
31. [Contact allergy for corticosteroids]. de Groot AC; van Ginkel CJ; Bruynzeel DP Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1559-62. PubMed ID: 9543750 [TBL] [Abstract][Full Text] [Related]
32. [Ulcer due to steroid ointments]. Echternacht K; Happle R Z Hautkr; 1974 Sep; 49(17):745-51. PubMed ID: 4440078 [No Abstract] [Full Text] [Related]
33. [A new steroid for the treatment of psoriasis and eczema]. Fredriksson T Lakartidningen; 1973 Aug; 29(35):2967-8. PubMed ID: 4790430 [No Abstract] [Full Text] [Related]
34. [Comparative studies with Halcinonide and fluocortolone in local administration]. Reinhard W; Weber G; Petres J Z Hautkr; 1974 Apr; 49(7):267-72. PubMed ID: 4275779 [No Abstract] [Full Text] [Related]
35. [Use of glucocorticoids in dermatitis]. Wozniak KD Z Arztl Fortbild (Jena); 1987; 81(15):789-91. PubMed ID: 3687094 [No Abstract] [Full Text] [Related]
36. Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig. Aldridge RD; Thomson AW; Rankin R; Whiting PH; Cunningham C; Simpson JG Clin Exp Immunol; 1985 Jan; 59(1):23-8. PubMed ID: 3971598 [TBL] [Abstract][Full Text] [Related]
37. Optimal efficacy of topical corticoids in psoriasis. Lidén S Semin Dermatol; 1992 Dec; 11(4):275-7. PubMed ID: 1493090 [TBL] [Abstract][Full Text] [Related]
40. [Determination of the effect of formulation on the bioavailability of topical corticoids by non-contact reflectometry]. Le Gall F; Levèque JL; Poelman MC Pharm Acta Helv; 1985; 60(4):125-8. PubMed ID: 4011625 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]